Parker-Hannifin Operating Cash Flow increased by 14.2% to $984.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.2%, from $630.03M to $984.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 10.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $693.60M | $424.36M | $581.11M | $542.97M | $893.29M | $457.36M | $618.78M | $718.76M | $1.19B | $649.96M | $702.03M | $795.09M | $1.24B | $743.98M | $934.76M | $630.03M | $1.47B | $782.00M | $862.00M | $984.00M |
| QoQ Change | — | -38.8% | +36.9% | -6.6% | +64.5% | -48.8% | +35.3% | +16.2% | +64.9% | -45.2% | +8.0% | +13.3% | +55.6% | -39.9% | +25.6% | -32.6% | +132.9% | -46.7% | +10.2% | +14.2% |
| YoY Change | — | — | — | — | +28.8% | +7.8% | +6.5% | +32.4% | +32.7% | +42.1% | +13.5% | +10.6% | +4.4% | +14.5% | +33.2% | -20.8% | +18.6% | +5.1% | -7.8% | +56.2% |